Navigation Links
Cure for food allergies is less than a decade away

Scientists made an announcement on September 8 that treatment for a broad range of food allergies will be available in less than ten years. Researchers have found// treatments by altering the proteins in the food that cause allergic reaction. These treatments harmlessly desensitize the body’s immune system.

"Therapies for food allergy will be on the market within seven to 10 years," said Ronald van Ree, of the University of Amsterdam, who is leading work on the development of treatments.

The overreaction of the cells of the immune system called immunoglobulin E (IgE) to protein molecules that are normally harmless leads to an allergic reaction. These protein molecules are called allergens and are present in cats, horses, nuts, milk and pollen.

In Britain, some form of allergy affects 30% of adults and 40% of the kids, says the Royal College of Physicians (RCP). The number is on the rise.

Peanut allergy was not very common in 1990, however, 1 in 200 children were affected by it in 1996. Now, the figure may have risen to as high as 1 in 50.

In 2003, it was concluded by the RCP that the highest prevalence of allergy in Europe was in Britain. It was among the highest in the world.

"For food allergy, the only treatment is avoidance and rescue medication if you're not successful in avoiding the food you're allergic to," said Dr Van Ree.

"Because the allergens are well known, I was able to artificially produce them, but with a difference. We can change the molecules so that IgE antibodies do not bind to the allergen any more."

"If we can fool the immune system in such a way that we can mimic chronic exposure by taking microbial or parasitical factors and adding them, then we might be able to shorten the treatment," he said.

There was a decrease in reactions by a factor of 10, with the modified versions of the allergens in apples produced by Dr Van Ree. Research is being done i n the U.S. on the mutated version of the allergens on peanuts.
GYT
'"/>




Related medicine news :

1. New drug helps allergies
2. How to determine allergies?
3. DNA vaccine for ragweed allergies
4. Fermented Milk offers protection against allergies in infants
5. See, men cause allergies in women after sex
6. A decade of service to cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: